SANJIVANI PARANTERAL
|
SANJIVANI PARANTERAL Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Profit Before Tax | ₹10 Cr | ₹7.57 Cr |
| Adjustment | ₹0.73 Cr | ₹0.77 Cr |
| Changes In working Capital | ₹2.64 Cr | ₹-18 Cr |
| Cash Flow after changes in Working Capital | ₹14 Cr | ₹-9.59 Cr |
| Cash Flow from Operating Activities | ₹12 Cr | ₹-11 Cr |
| Cash Flow from Investing Activities | ₹-22 Cr | ₹-12 Cr |
| Cash Flow from Financing Activities | ₹10 Cr | ₹23 Cr |
| Net Cash Inflow / Outflow | ₹0.94 Cr | ₹0.24 Cr |
| Opening Cash & Cash Equivalents | ₹0.54 Cr | ₹0.30 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹1.49 Cr | ₹0.54 Cr |
Compare Cashflow Statement of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹159.0 Cr | -13.7% | -25.2% | -42.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,195.0 Cr | 0.9% | 12.7% | 8.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,993.0 Cr | -0.4% | 9.7% | 11.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,926.0 Cr | 0.5% | 5.8% | 36.5% | Stock Analytics | |
| CIPLA | ₹113,052.0 Cr | -2.7% | 13.9% | -6.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,333.0 Cr | 1.5% | 7.3% | 8% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | -13.7% |
-25.2% |
-42.4% |
| SENSEX | 1% |
-4.1% |
-7.4% |
You may also like the below Video Courses